These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20501643)

  • 1. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.
    Tennis MA; Van Scoyk MM; Freeman SV; Vandervest KM; Nemenoff RA; Winn RA
    Mol Cancer Res; 2010 Jun; 8(6):833-43. PubMed ID: 20501643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma.
    Winn RA; Van Scoyk M; Hammond M; Rodriguez K; Crossno JT; Heasley LE; Nemenoff RA
    J Biol Chem; 2006 Sep; 281(37):26943-50. PubMed ID: 16835228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
    Winn RA; Marek L; Han SY; Rodriguez K; Rodriguez N; Hammond M; Van Scoyk M; Acosta H; Mirus J; Barry N; Bren-Mattison Y; Van Raay TJ; Nemenoff RA; Heasley LE
    J Biol Chem; 2005 May; 280(20):19625-34. PubMed ID: 15705594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer.
    Avasarala S; Bikkavilli RK; Van Scoyk M; Zhang W; Lapite A; Hostetter L; Byers JT; Heasley LE; Sohn JW; Winn RA
    PLoS One; 2013; 8(10):e76895. PubMed ID: 24204697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.
    Zhang C; Wang H; Liu X; Hu Y; Ding L; Zhang X; Sun Q; Li Y
    Oncogene; 2019 Mar; 38(11):1892-1904. PubMed ID: 30390072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.
    Tennis MA; Van Scoyk M; Heasley LE; Vandervest K; Weiser-Evans M; Freeman S; Keith RL; Simpson P; Nemenoff RA; Winn RA
    Neoplasia; 2010 Mar; 12(3):244-53. PubMed ID: 20234818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).
    Bren-Mattison Y; Van Putten V; Chan D; Winn R; Geraci MW; Nemenoff RA
    Oncogene; 2005 Feb; 24(8):1412-22. PubMed ID: 15608671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancer.
    Bikkavilli RK; Zerayesus SA; Van Scoyk M; Wilson L; Wu PY; Baskaran A; Tang K; Raheem S; Samuelson BA; Reddy NM; Reddy SP; Cool CD; Kosmider B; Avasarala S; Winn RA
    J Biol Chem; 2017 May; 292(18):7423-7434. PubMed ID: 28275056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail.
    Choudhary R; Li H; Winn RA; Sorenson AL; Weiser-Evans MC; Nemenoff RA
    Neoplasia; 2010 Mar; 12(3):224-34. PubMed ID: 20234816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer.
    Tennis MA; Vanscoyk MM; Wilson LA; Kelley N; Winn RA
    PLoS One; 2012; 7(3):e32921. PubMed ID: 22403725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
    So WK; Cheng JC; Liu Y; Xu C; Zhao J; Chang VT; Leung PC
    Tumour Biol; 2016 Jul; 37(7):9197-207. PubMed ID: 26768617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
    Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
    Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC.
    Ciaramella V; Sasso FC; Di Liello R; Corte CMD; Barra G; Viscardi G; Esposito G; Sparano F; Troiani T; Martinelli E; Orditura M; De Vita F; Ciardiello F; Morgillo F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):178. PubMed ID: 31027492
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Guo J; Zhu H; Li Q; Dong J; Xiong W; Yu K
    Aging (Albany NY); 2021 Apr; 13(8):11665-11677. PubMed ID: 33879635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells.
    Feng S; Zhai J; Lu D; Lin J; Dong X; Liu X; Wu H; Roden AC; Brandi G; Tavolari S; Bille A; Cai K
    Exp Cell Res; 2018 Dec; 373(1-2):44-56. PubMed ID: 30098333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.